and specific for, young individuals with a first episode psychosis (FEP), by directly comparing them with typically developing peers and adolescents with ADHD. Methods: 27 FEP patients, 25 ADHD patients and 45 age and gender matched Healthy Controls (HC), all aged between 12 and 17 years old, were assessed for their N1, N2, P2, P3a, P3b, MMN and PN amplitudes in a selective attention paradigm (auditory oddball task). Results: ADHD patients showed significantly smaller N2 and P3b amplitudes than HC, whereas FEP patients showed intermediate amplitudes. In addition, we found a second order interaction effect, indicating that the HC group had larger P2 amplitudes to attended deviant stimuli than to unattended deviant stimuli, whereas the response to non-attended deviant stimuli did not differ from that to non-attended standard stimuli. The ADHD group did not show this difference, in fact, they showed P2 amplitudes to unattended deviant stimuli that were larger than those to unattended standards. Interestingly, this effect was also found in the FEP group, although this only reached trend level (p = 0.08) of statistical significance. Post-hoc dividing the FEP group in patients with and without a diagnosis of schizophrenia, showed the same second order interaction effect in patients without schizophrenia as that in the ADHD subjects, while the interaction effect in patients with schizophrenia was identical to that of the HC. Furthermore, FEP patients without schizophrenia showed significantly smaller P3b amplitudes compared to FEP patients with schizophrenia and HC. Last, FEP patients with schizophrenia showed trend level significant smaller MMN amplitudes than HC (p = 0.09). No further significant group differences were found. Discussion: FEP patients without schizophrenia showed impaired neurophysiological functioning compared to their counterparts with schizophrenia, who in turn showed similar performance as healthy controls. Given that use of medication did not differ between FEP patients with and without schizophrenia, our data suggest that other factors may play a role, such as comorbid symptoms. Since we found considerable overlap between FEP patients without schizophrenia and ADHD patients our current data do not support the theory that any of the investigated electrophysiological measures are useful as specific biomarkers for schizophrenia.
NORMENT K.G. Jebsen Center for Psychosis ResearchUniversity of Bergen
Background: Although the role of lipid disturbances and inflammation in psychotic disorders have been demonstrated in a substantial body of research, the association between clinical symptomatology and these two important pathways has not been studied in detail. The main aim of this study was to investigate the associations between serum lipid levels [total cholesterol (TC), low density lipoprotein (LDL), triglyceride (TG)]; general or specific inflammatory markers [C-reactive protein (CRP), soluble tumor necrosis factor receptor 1(sTNF-R1), osteoprotegerin (OPG), interleukin 1 receptor antagonist (IL-1Ra)]; and clinical symptoms (positive, negative and depressive) in patients with psychotic disorders. Methods: The sample is consisted of 652 participants divided in two groups: Schizophrenia, schizophreniform and schizoaffective, (schizophrenia group, N = 344); psychosis NOS, psychotic bipolar I, II and NOS, (non-schizophrenia group, N = 308) recruited consecutively between 2003 and 2015 from five major hospitals in Oslo, Norway, as part of Thematically Organized Psychosis (TOP) Study. The Regional Committee for Medical Research Ethics approved the study. Demographic, clinical and medications data were obtained by clinical interviews and from medical records. SCID-I was used for diagnosis in addition to Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for Schizophrenia (CDSS) to assess symptoms severity. Bivariate and multivariate analyses were performed to evaluate associations between symptom profiles, lipid levels and inflammatory markers. Results: Schizophrenia group showed higher levels of TC and LDL compared to non-schizophrenia group after adjusting for age, gender, BMI, smoking, and medications. TC and LDL were positively correlated with depression, whereas TG and LDL were positively correlated with negative symptoms. CRP and OPG were significantly associated with higher levels of TC and LDL. While, sTNF-R1 showed significant positive correlation only with TG. In multivariate regression, higher LDL was significantly associated with higher age, BMI, depressive severity in addition to two inflammatory markers CRP and OPG. Discussion: The findings of this study highlight the importance of understanding the interaction between inflammatory markers and lipid, and their relation to clinical profile especially depression in psychotic disorders 
F23. LOW-GRADE INFLAMMATORY PROFILE IN FIRST-EPISODE PSYCHOSIS: RESULTS FROM THE STREAM STUDY IN BRAZIL

University of São Paulo, Ribeirão Preto School of Medicine
Background: The inflammatory hypothesis of schizophrenia suggests that abnormalities in inflammatory factors may contribute to the onset of this disease early in adulthood. Nevertheless, no study has investigated possible effects of shared environment by looking at cytokine levels in healthy siblings of first-episode psychosis patients (FEP). The aim of this study was to investigate inflammatory cytokine (IL-6, IL-10, TNF-a) abnormalities in a sizeable epidemiological-based sample of FEP patients, their healthy siblings and population-based controls. Methods: This study is part of the epidemiological investigation "Schizophrenia and Other Psychoses Translational Research: Environment and Molecular Biology" (STREAM), conducted in Ribeirão Preto (São Paulo, Brazil) and surrounding area, which is part of the international consortium "European Network of National Schizophrenia Networks Studying Gene-Environment Interactions" (EU-GEI). We recruited a total sample of 507 participants, composed by 166 FEP patients (64% males; mean age: 30.3 ± 12.2), 76 siblings (30.3% males; mean age: 31.5 ± 11.0) and 265 population-based controls (50.2% males; mean age: 31.7 ± 11.2). Plasma cytokines IL-6, TNF-a and IL-10 were analysed by Multiplex Bead Array (Luminex xMap technology). We performed the multivariate general linear model (GLM) analysis with age as covariate, cytokines as dependent variables and diagnostic group and sex as explanatory variables. Results: We found significant differences between the three groups [F (6,994) = 10.864; p < 0.001] in the plasma concentration of all the three cytokines (p < 0.001), independent of the sex of the participants (p = 0.115; interaction diagnosis & sex p = 0.115). FEP patients had significantly higher levels of IL-6, TNF-a, and IL-10 when compared to controls (p < 0.001 for all). When compared to their siblings, patients had higher levels of both TNF-a and IL-10 (p < 0.05 for both), and a trend to IL-6 (p = 0.058), whereas siblings did not differ from controls for any of the three cytokines analysed (p > 0.05 for all). Discussion: This is the first study conducted in the South hemisphere to demonstrate the low-grade inflammatory profile in FEP patients, compared to their siblings and community-based controls. The fact that IL-6, TNF-a and IL-10 are all higher in the FEP group than their healthy siblings and community-based controls suggests the synergism of individual vulnerability factors in the development of this inflammatory profile.
